Dementia drug from Alector fails to slow patient decline in trial
An experimental drug from Alector Inc. failed to slow the decline of patients with frontotemporal dementia in a late-stage study, ...
An experimental drug from Alector Inc. failed to slow the decline of patients with frontotemporal dementia in a late-stage study, ...
Alector Therapeutics said Monday that its Phase 2 trial for an experimental Alzheimer’s antibody failed, dealing a blow to what ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.